MediTox s.r.o.

Main activities

Non clinical R & D related to ophthalmic diseases (chronic glaucoma), osteoarthritis (ACLT, CCLT, dogs, rabbits), non-clinical development of vaccines (influenza, adenovirus, etc.).

Comprehensive non-clinical and toxicological program for assessment of human/veterinary drugs, vaccines, biological products, medical devices and food/feed additives (EMA/ICH/VICH/FDA/ISO), chemical substances and preparations (ECHA)

Models of selected human diseases - chronic glaucoma, contact dermatitis, osteoarthritis, human influenza

Accredited breeding facility (CZ 02396)

MediTox s.r.o.

MediTox s.r.o. is a GLP-certified preclinical contract research organization offering a wide range of preclinical development services taking advantage of wealth of experience in variety of therapeutics areas, biotechnology, chemical and agrochemical industry and research collaboration with universities and research institutions.

MediTox R&D activities are pointed to collaborative scientific and research projects within international and national framework.

The strong points of MediTox ensure personalized and comprehensive contract research (one-stop-shop), high professional standard together with flexibility and competitive pricing.

We will attend following events:

ToxExpo 2023, March 20 – 22, 2023, Nashville, USA

ToxExpo 2023

CEBioForum 2022, April 18-19, 2023, Warsaw, Poland

CebioForum 2023

Nordic Life Sciences 2023, November 29 – 30, 2023, Copenhagen, Denmark

Nordic Life Sciences 2023

BioFIT 2023, December 12 – 13, 2023, Marseille, France

BioFIT 2023

MediTox s.r.o.

MediTox s.r.o.

MediTox s.r.o.